⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10199831 | 1.00 | — | — | |
| SCHEMBL863130 | 1.00 | — | — | |
| SCHEMBL7678621 | 0.78 | — | — | |
| SCHEMBL19230493 | 0.78 | — | — | |
| SCHEMBL13527678 | 0.78 | — | — | |
| SCHEMBL24154544 | 0.74 | — | — | |
| SCHEMBL6576623 | 0.74 | — | — | |
| SCHEMBL3390705 | 0.74 | — | — | |
| SCHEMBL16355120 | 0.74 | — | — | |
| SCHEMBL14378298 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111100886-B | Biosynthesis method of N-methyl pyrroline | 中国科学院分子植物科学卓越创新中心 | 2021-07-20 | — | — | CN | claimed |
| CN-111100886-A | Biosynthesis method of N-methyl pyrroline | 中国科学院上海生命科学研究院 | 2020-05-05 | — | — | CN | claimed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | claimed |
| EP-1021200-B1 | METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS | BASF AG (DE) | 2002-02-06 | — | — | EP | claimed |
| US-20010009901-A1 | Antineoplastic peptides | BASF AKTIENGESELLSCHAFT GERMANY | 2001-07-26 | — | — | US | claimed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | claimed |
| EP-0866800-A2 | ANTINEOPLASTIC PEPTIDES | BASF AKTIENGESELLSCHAFT (DE) | 1998-09-30 | — | — | EP | claimed |
| WO-1997022621-A2 | ANTINEOPLASTIC PEPTIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-06-26 | — | — | WO | claimed |
| US-12018265-B2 | Nucleic acid encoding n-methylputrescine oxidase and uses thereof | 22ND CENTURY LIMITED, LLC (US) | 2024-06-25 | — | — | US | disclosed |
| US-20240191267-A1 | Tropane Alkaloid Transporters and Methods of Making Tropane Alkaloids Using the Same | HERCULES CAPITAL, INC., AS AGENT | 2024-06-13 | — | — | US | disclosed |
| CN-118055766-A | Magic and non-magic serotonin receptor agonist and its preparing process and usage | 库莱恩有限责任公司 | 2024-05-17 | — | — | CN | disclosed |
| CN-117342994-A | Synthesis method of N-methyl-5-methoxy tryptamine | 河北维达康生物科技有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-114047267-B | Method for analyzing nicotinic acid in tobacco root system by derivatization-gas chromatography-mass spectrometry | 贵州省烟草科学研究院 | 2023-11-21 | — | — | CN | disclosed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | disclosed |
| US-20010009901-A1 | Antineoplastic peptides | BASF AKTIENGESELLSCHAFT GERMANY | 2001-07-26 | — | — | US | disclosed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | disclosed |
| EP-0866800-A2 | ANTINEOPLASTIC PEPTIDES | BASF AKTIENGESELLSCHAFT (DE) | 1998-09-30 | — | — | EP | disclosed |
| WO-1997022621-A2 | ANTINEOPLASTIC PEPTIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-06-26 | — | — | WO | disclosed |